Clearmind Signs Development and Supply Agreement to Produce Its Drug Candidate MEAI Psychedelic Molecule With Aragen Life Sciences
October 26, 2021 08:00 ET
|
Clearmind Medicine
TORONTO, Ontario, Oct. 26, 2021 (GLOBE NEWSWIRE) -- via InvestorWire – Clearmind Medicine Inc. (CSE: CMND, FSE: CWY0), (“Clearmind” or the "Company"), a psychedelic medicine biotech company focused...
Clearmind Medicine to Host ‘Psychedelics for Alcoholism‘ Virtual Educational Event on October 20
October 01, 2021 08:00 ET
|
Clearmind Medicine
TORONTO, Oct. 01, 2021 (GLOBE NEWSWIRE) -- via InvestorWire – Clearmind Medicine Inc. (CSE: CMND) (“Clearmind” or the "Company"), a psychedelic medicine biotech company focused on the discovery and...
Novamind to Present at Life Sciences Investor Forum
September 15, 2021 08:35 ET
|
Life Sciences Investor Forum
TORONTO, Sept. 15, 2021 (GLOBE NEWSWIRE) -- Novamind Inc. (CSE: NM | OTCQB: NVMDF | FSE: HN2) (“Novamind” or the “Company”), a leading mental health company specialized in psychedelic medicine, is...
Microdose Psychedelic Insights Presents the Upcoming DMT Conference, a Deep Dive Into the Dynamic Field of DMT Therapeutics
August 30, 2021 09:35 ET
|
Microdose Psychedelic Insights
NEW YORK, Aug. 30, 2021 (GLOBE NEWSWIRE) -- via NetworkNewsWire -- Microdose Psychedelic Insights, a cutting-edge media company focused on promoting content, financial analysis, and engaging events...
Microdose Psychedelic Insights to Host Psychedelic Capital Conference this Month
August 13, 2021 09:35 ET
|
Microdose Psychedelic Insights
NEW YORK, Aug. 13, 2021 (GLOBE NEWSWIRE) -- via NetworkNewsWire -- -- Microdose Psychedelic Insights is a cutting-edge media company focused on creating compelling content, distributing financial...
Mindset Pharma Announces Promising Test Results of its Novel and Proprietary Psilocybin-Inspired Compounds
August 31, 2020 07:00 ET
|
Mindset Pharma Inc.
TORONTO, Aug. 31, 2020 (GLOBE NEWSWIRE) -- Mindset Pharma ("Mindset"), a leading drug discovery and development business focused on next-generation psychedelic medicines to treat neuropsychiatric...
PSYC Continuing Its Path of Becoming Content Leader in The Psychedelic Space Through Key Interviews
August 25, 2020 08:30 ET
|
Global Trac Solutions, Inc.
LAS VEGAS, Aug. 25, 2020 (GLOBE NEWSWIRE) -- Global Trac Solutions, Inc. (OTCPink: PSYC) (“Global” “PSYC” or the “Company”) is pleased to announce that as the Company continues to ramp-up efforts...
U.S. Small Cap Stocks Could Outperform The Market During The Recovery And Here Are Four Stocks You Need To Know About
July 22, 2020 07:00 ET
|
OTC Stock Review
ATLANTA, July 22, 2020 (GLOBE NEWSWIRE) -- According to Premier Miton Fund Manager Nick Ford in a recent CNBC’s “Squawk Box Europe” interviewi, U.S. small cap stocks are set to outperform the...
North Sur Resources and Mindset Pharma Announce Proposed Transaction to Accelerate Development of Medical Psychedelics Industry
June 29, 2020 16:15 ET
|
Mindset Pharma Inc.
VANCOUVER, British Columbia, June 29, 2020 (GLOBE NEWSWIRE) -- North Sur Resources Inc. (“North Sur”) and Mindset Pharma Inc. (“Mindset”) are pleased to announce that they have signed a binding...
PSYC Primed for Launch During Covid-19
April 21, 2020 08:30 ET
|
Global Trac Solutions, Inc.
Las Vegas, NV, April 21, 2020 (GLOBE NEWSWIRE) -- Global Trac Solutions, Inc. (OTCPink: PSYC) (“Global” “PSYC” or the “Company”) is pleased to announce they have engaged with a variety of key...